查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1715773

經皮貼片市場按產品類型、活性成分、遞送系統、應用、最終用戶和細分類型分類－2025-2030 年全球預測

Transdermal Patches Market by Product Type, Active Ingredient, Delivery System, Application, End User, Layer Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年經皮貼片市場價值將達到 79.5 億美元，到 2025 年將以 5.16% 的複合年成長率成長至 83.4 億美元，到 2030 年將達到 107.5 億美元。

主要市場統計數據
基準年2024年 79.5億美元
預計2025年 83.4億美元
預測年份 2030 107.5億美元
複合年成長率（%） 5.16%

經皮吸收貼片市場處於藥物傳遞的前沿，結合了先進的技術與以消費者為中心的優勢。本報告探討了市場促進因素、技術創新和不斷變化的消費者需求，以重塑藥物輸送方式。經皮吸收貼片可以長期、非侵入性、可控制且穩定地輸送活性物質，提高患者的遵從性和舒適度。在個人化醫療和先進配方技術處於前沿的時代，經皮給藥系統已成為管理慢性疾病和改善治療效果的重要組成部分。經濟壓力、監管改革以及全球對以患者為中心的模式的關注都在共同重新定義市場重點。這項全面概述深入探討了市場動態、競爭格局和區域差異，為決策者提供相關見解和可操作的數據。從貼片設計的創新到複雜的製造程序，介紹為深入探索市場奠定了基調，在技術嚴謹性和巨大的商業性潛力之間取得了平衡。隨後的討論整合了新興趨勢和策略細分，以提供既具有廣闊視角又具有詳細技術細節的明智觀點。

這種動態格局要求相關人員重新評估傳統的經營模式，同時抓住先進材料和配方技術所提供的機會。以下部分對市場變化、細分洞察、區域差異化以及推動經皮貼片創新的主要企業說明了深入分析。

重新定義市場格局的轉捩點

近年來，經皮貼片市場經歷了徹底的變革，從根本上重新定義了市場格局。材料科學和藥物配方的發展促進了貼劑的開發，從而提高了貼劑的滲透性、黏附性，並提供了更精確的控制釋放曲線。新興技術正在為智慧感測器和回饋機制的整合鋪平道路，這些技術將徹底改變治療方法的監測和調整方式。此外，多個地區的監管機構已經建立了強力的框架，支持創新同時確保病患安全，加速了下一代貼片的市場推廣。

技術進步、消費者偏好的不斷變化以及全球向非侵入性治療方法的轉變，正在促使人們重新評估既定的通訊協定。醫療保健專業人士越來越提倡提供穩定藥物動力學特徵、減少不利事件可能性並提高患者依從性的治療方法。醫療成本上漲和最佳化資源的需求等經濟因素也使得經皮給藥系統具有戰略重要性。

在市場劇烈動盪的時期，企業正大力投資研發，並與學術機構和研究中心合作，進一步突破創新的界限。這些努力正逐步重塑競爭格局，並培育新的策略遠見環境。因此，市場領導正在重新考慮產品系列和業務策略，以在快速變化的市場環境中保持領先地位。

揭示市場動態的關鍵細分洞察

詳細的細分分析揭示了推動經皮貼片市場發展的不同方面。就產品類型而言，市場分為黏合劑貼片、基質貼片和微型儲庫貼片。自黏類型進一步分為多層和單層類型，這種區別突出了配方中的細微差別。類似地，也對多層和單層的基質貼片類別進行了評估，以深入了解材料的穩健性和釋放動力學。這種分層細分可以更深入地了解設計特性和製造挑戰，每個子集都解決了獨特的治療需求。

活性成分的細分揭示了可透過貼片輸送的多種化合物。Buprenornhine、可樂定、Fentanyl、Lidocaine和尼古丁等關鍵成分是不斷發展的產品系列的核心，每種成分都表現出獨特的動態特性和臨床指徵。此外，輸送系統的細分區分了控制釋放和直接釋放，這會影響劑量一致性和患者體驗。值得注意的是，基於應用的細分涵蓋了各種治療領域，如心血管疾病、荷爾蒙補充療法、神經系統疾病、疼痛管理、戒菸、傷口處理等。例如，對於心血管疾病，可樂定和硝酸異山梨酯貼片受到特別關注，而對於荷爾蒙補充療法，有多種可供選擇的方案，包括荷爾蒙組合貼片、雌激素貼片和黃體素貼片。此外，疼痛管理解決方案反映了進一步的細分，例如基於雙氯芬酸鈉的製劑、基於Fentanyl的製劑和基於Lidocaine的製劑。

最終用戶洞察探索這些補丁最常部署在哪裡。從門診手術中心和居家醫療機構，到醫院、診所、專門研究實驗室和學術機構，用途的多樣性表明了這些解決方案的深遠影響。最後，基於層類型（區分多層和單層配置）的分割提供了進一步的理解。這種複雜的細分矩陣使行業相關人員能夠制定策略，以最佳方式滲透到每個細分市場，確保技術和消費群的創新始終處於市場發展的前沿。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 家庭醫療保健領域對實用、高效的藥物管理解決方案的需求日益成長
      • 慢性病的增加催生了對替代性疼痛管理解決方案的需求
      • 新技術進步提高經皮貼片的有效性和便利性
    • 限制因素
      • 影響經皮貼片功效和安全性的生物相容性問題。
    • 機會
      • 將物聯網技術整合到智慧經皮貼片中，實現即時健康監測
      • 個人化醫療的快速發展產生了對可客製化經皮吸收貼片解決方案的需求。
    • 任務
      • 解決經皮吸收貼片產業的智慧財產權和專利到期威脅
  • 市場區隔分析
    • 產品類型：多層藥物貼片的滲透性大大提高，可容納複雜的藥物組合。
    • 最終用戶：醫院和診所對廣譜頻譜的需求不斷成長
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章經皮貼片市場（依產品類型）

  • 含藥貼劑
    • 多層藥物貼片
    • 單層藥物內貼劑
  • 矩陣補丁
    • 多層矩陣
    • 單層矩陣
  • 微型儲液罐貼片

經皮貼片市場（依活性成分）

  • Buprenornhine
  • 可樂定
  • Fentanyl
  • Lidocaine
  • 尼古丁

第 8 章經皮貼片市場（依遞送系統）

  • 控釋
  • 直接髮布

經皮貼片市場（依應用）

  • 心血管疾病
    • 可樂定貼劑
    • 硝酸異山梨酯貼片
  • 荷爾蒙補充療法
    • 聯合荷爾蒙貼劑
    • 雌激素貼片
    • 黃體素貼劑
  • 神經系統疾病
  • 疼痛管理
    • 雙氯芬酸鈉
    • Fentanyl
    • Lidocaine鹼
  • 禁止抽煙
  • 傷口處理

第 10 章經皮貼片市場（依最終用戶分類）

  • 門診手術中心
  • 居家照護環境
  • 醫院和診所
  • 研究和學術機構

經皮貼片市場（按層類型）

  • 多層
  • 單層

12.美洲經皮貼片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

13. 亞太地區經皮貼片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

14. 歐洲、中東和非洲經皮貼片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc.
  • AdhexPharma SAS
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioNxt Solutions Inc.
  • Bliss GVS Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • Corsair Pharma, Inc.
  • DifGen Pharmaceuticals LLC
  • Endo International plc
  • Gedeon Richter Plc
  • GlaxoSmithKline Plc
  • Icure Pharmaceutical Inc.
  • Johnson & Johnson Services, Inc.
  • LAVIPHARM GROUP HOLDING SA
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Medherant Limited
  • Nitto Denko Corporation
  • Novartis AG
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
  • Nutriband Inc
  • Perrigo Company plc
  • ProSolus, Inc.
  • Purdue Pharma LP
  • Sparsha Pharma International Pvt Ltd
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Group
Product Code: MRR-FD3F12D540F6

The Transdermal Patches Market was valued at USD 7.95 billion in 2024 and is projected to grow to USD 8.34 billion in 2025, with a CAGR of 5.16%, reaching USD 10.75 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.95 billion
Estimated Year [2025] USD 8.34 billion
Forecast Year [2030] USD 10.75 billion
CAGR (%) 5.16%

The transdermal patches market represents a cutting-edge frontier in drug delivery, combining advanced technology with consumer-centric benefits. This report introduces key market drivers, technological innovations, and evolving consumer needs that are reshaping how medications are administered. Transdermal patches offer a non-invasive and controlled method of delivering actives steadily over a prolonged period, ensuring improved patient adherence and comfort. In an era where personalized medicine and advanced formulation technologies are at the forefront, the transdermal delivery system has emerged as an essential component in managing chronic conditions and enhancing therapeutic efficacy. Economic pressures, regulatory reforms, and a global emphasis on patient-centric models are all converging to redefine market priorities. This comprehensive overview delves into market dynamics, competitive landscapes, and geographic variations, ensuring that decision-makers are fully equipped with relevant insights and actionable data. From innovation in patch design to refined manufacturing processes, the introduction sets the tone for a detailed exploration of a market that balances technological rigor with significant commercial promise. The discussion that follows integrates emerging trends with strategic segmentation, offering an informed perspective that is both broad in scope and detailed in technical specificity.

In this dynamic landscape, stakeholders are called upon to re-evaluate traditional business models while embracing the opportunities brought forth by advanced materials and formulation techniques. The ensuing sections provide a thorough analysis of market shifts, segmentation insights, regional differentiators, and the key corporate players that are driving forward innovation in transdermal patch solutions.

Transformative Shifts Redefining the Market Landscape

Over recent years, the transdermal patches market has experienced transformative shifts that have fundamentally redefined its landscape. Advances in material science and drug formulation have facilitated the development of patches that offer enhanced permeability, improved adhesion, and more precise controlled release profiles. Emerging technologies have paved the way for the integration of smart sensors and feedback mechanisms, which are set to revolutionize how therapeutic regimens are monitored and adjusted over time. Regulatory bodies across multiple regions have also established robust frameworks that support innovation while ensuring patient safety, thereby opening doors for the accelerated introduction of next-generation patches into the market.

In addition to technological advancements, evolving consumer preferences and a global shift toward non-invasive treatment options have spurred a re-evaluation of established protocols. Healthcare professionals are increasingly advocating for treatments that provide steady pharmacokinetic profiles, reducing the likelihood of adverse events and improving patient compliance. Economic drivers, including rising healthcare costs and the need for resource optimization, have also reinforced the strategic importance of transdermal delivery systems, as they often reduce the need for frequent dosing and hospital visits.

This period of significant market disruption has prompted companies to invest heavily in R&D, forming collaborations with academic institutions and research centers to push the envelope of innovation further. These initiatives are gradually reshaping competitive dynamics and fostering an environment of renewed strategic foresight. Consequently, market leaders are rethinking product portfolios and operational strategies in a bid to stay ahead in a rapidly evolving market environment.

Key Segmentation Insights Illuminating Market Dynamics

Detailed segmentation analysis provides a clearer picture of the diverse dimensions propelling the transdermal patches market. When considering product type, the market is dissected into drug-in-adhesive patches, matrix patches, and micro-reservoir patches. The drug-in-adhesive segment further branches into multi-layer and single-layer variants, a distinction that underscores the nuanced approaches in formulation. Similarly, the matrix patches category is evaluated for multi-layer and single-layer differences, providing insight into material robustness and release kinetics. This layered segmentation offers a deeper understanding of design specifics and manufacturing challenges as each subset caters to unique therapeutic requirements.

The active ingredient segmentation sheds light on the variety of compounds being delivered via patches. Key ingredients such as buprenorphine, clonidine, fentanyl, lidocaine, and nicotine are central to the evolving product portfolio, each representing unique pharmacodynamic profiles and clinical indications. Further, the delivery system segmentation distinguishes between controlled release and direct release, which impact the dosage consistency and patient experience. Notably, application-based segmentation spans across various therapeutic areas including cardiovascular disorders, hormone replacement therapy, neurological conditions, pain management, smoking cessation, and wound management. For instance, within cardiovascular disorders, special focus is given to clonidine and isosorbide dinitrate patches, whereas hormone replacement therapy options are diversified into combination hormone, estrogen, and progestin patches. Pain management solutions also reflect further segmentation through diclofenac-based, fentanyl-based, and lidocaine-based formulations.

End user insights explore where these patches are most commonly deployed. From ambulatory surgical centers and homecare settings to hospitals, clinics, and specialized research and academic institutes, the diversity in usage underscores the extensive reach of these solutions. Finally, segmentation based on layer type - distinguishing multi-layer versus single-layer configurations - further refines our understanding. This intricate segmentation matrix provides industry players with the ability to tailor strategies for optimum penetration of each niche segment, ensuring that both technological and consumer-based innovations remain at the forefront of market development.

Based on Product Type, market is studied across Drug-In-Adhesive Patches, Matrix Patches, and Micro-Reservoir Patches. The Drug-In-Adhesive Patches is further studied across Multi-Layer Drug-In-Adhesive Patches and Single-Layer Drug-In-Adhesive Patches. The Matrix Patches is further studied across Multi-Layer Matrix and Single-Layer Matrix.

Based on Active Ingredient, market is studied across Buprenorphine, Clonidine, Fentanyl, Lidocaine, and Nicotine.

Based on Delivery System, market is studied across Controlled Release and Direct Release.

Based on Application, market is studied across Cardiovascular Disorders, Hormone Replacement Therapy, Neurological Conditions, Pain Management, Smoking Cessation, and Wound Management. The Cardiovascular Disorders is further studied across Clonidine Patches and Isosorbide Dinitrate Patches. The Hormone Replacement Therapy is further studied across Combination Hormone Patches, Estrogen Patches, and Progestin Patches. The Pain Management is further studied across Diclofenac-Based, Fentanyl-Based, and Lidocaine-Based.

Based on End User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Research & Academic Institutes.

Based on Layer Type, market is studied across Multi-Layer and Single Layer.

Key Regional Insights Shaping the Global Market

Regional analysis reveals distinct market dynamics that vary significantly across different geographical landscapes. In the Americas, robust healthcare infrastructures combined with high consumer awareness drive demand for innovative and reliable transdermal solutions. Regions within this territory are characterized by strict regulatory standards that ensure product reliability and safety while encouraging technological advancements. Investors and market strategists continue to focus on growth prospects in this region due to its rapid adoption of non-invasive treatment modalities.

Across Europe, the Middle East, and Africa, a unique blend of mature healthcare systems and emerging market opportunities creates an environment ripe for innovation. European markets are leveraging established regulatory mechanisms to balance innovation with patient safety, while initiatives in the Middle East and Africa often display a growing demand for advanced therapeutics as both government and private sectors invest in modernizing healthcare infrastructure. The convergence of legacy systems and modern technology across these regions often results in tailored approaches to product development and market penetration.

In the Asia-Pacific region, dynamic economic developments, increasing disposable incomes, and rapid urbanization play a pivotal role in expanding market reach. Emerging healthcare demands, coupled with ongoing investments in research and development, have positioned the region as a significant hub for transdermal patch innovation. Overall, regional nuances are critical to understanding the broader market, as cultural, economic, and regulatory differences influence therapeutic adoption rates and shape strategic initiatives for market players around the globe.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Comprehensive Company Insights Driving Market Innovation

The competitive landscape of the transdermal patches market is defined by a cadre of innovative companies who are pushing the boundaries of research and development. Prominent industry players such as AbbVie Inc. and AdhexPharma SAS are at the forefront of integrating advanced materials and formulation technologies to produce next-generation patch solutions. Amneal Pharmaceuticals, Inc. and Bayer AG continue to contribute to market growth by focusing on patient-centric designs that enhance drug delivery efficiency and adherence. Start-ups and established entities alike, including BioNxt Solutions Inc. and Bliss GVS Pharma Ltd., are merging innovation with proven manufacturing techniques to maintain competitive advantages.

Large multinationals such as Boehringer Ingelheim International GmbH and Corium, Inc. have significantly influenced market practices by adopting strategic partnerships and prioritizing clinical efficacy. Other companies like Corsair Pharma, Inc. and DifGen Pharmaceuticals LLC bring specialized expertise into play, while Endo International plc, Gedeon Richter Plc, and GlaxoSmithKline Plc contribute to the evolution of clinical protocols through groundbreaking research. The vibrant competitive landscape is further enriched by players such as Icure Pharmaceutical Inc. and Johnson & Johnson Services, Inc., whose comprehensive product portfolios cater to diverse therapeutic needs. Companies including LAVIPHARM GROUP HOLDING S.A. and Lohmann Therapie-Systeme AG are well-regarded for their commitment to advancing transdermal technology. Additional market influencers like Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, and Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc. have also carved out significant market niches. The landscape is further expanded by innovators such as Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Teikoku Seiyaku Co., Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Group. Together, these companies drive market momentum by combining clinical expertise with dynamic innovation, pushing forward a market that continues to evolve at an unprecedented pace.

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Lohmann Therapie-Systeme AG, Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Teikoku Seiyaku Co., Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Group. Actionable Recommendations for Strategic Market Leadership

For industry leaders looking to secure a competitive edge in the transdermal patches market, several actionable strategies are recommended. First, investment in research and development is paramount. Leaders should focus on emerging technologies that enable enhanced drug delivery mechanisms and the integration of smart monitoring systems. This commitment to innovation will not only meet but exceed the growing demands for precision and efficacy in patient care. Collaborations with academic institutions and cross-disciplinary research teams can serve as a vital source of breakthrough ideas and facilitate faster time-to-market for novel products.

Furthermore, it is critical to adopt a market segmentation approach that is informed by detailed insights into product type, active ingredients, delivery systems, and application-specific requirements. Tailoring product offerings to meet the specific needs of diverse demographics and therapeutic areas will bolster market penetration. Strategic regional investments are also essential; understanding local regulatory environments and consumer behaviors across the Americas, Europe, the Middle East, Africa, and Asia-Pacific can help create targeted marketing strategies and streamlined supply chains.

Additionally, forging strategic partnerships with key opinion leaders, healthcare providers, and regulatory bodies will help in navigating evolving market conditions. Emphasizing sustainability and operational efficiency throughout the supply chain will further cement a company's position as a market leader. Ultimately, a forward-thinking approach, underpinned by continuous learning and agile adaptation to industry trends, will serve as the cornerstone for sustained success in this competitive and dynamic sector.

Conclusion: Summarizing Critical Market Insights

In summary, the transdermal patches market stands at the nexus of innovation and opportunity. This comprehensive analysis highlights the dynamic interplay between advanced formulation technologies, strategic segmentation, and evolving regulatory landscapes. By synthesizing key insights from product-type distinctions to geographic and operational dynamics, we gain a detailed understanding of how shifting consumer demands, technological advancements, and evolving healthcare models are reshaping the industry. The segmentation insights reveal intricate differences in product design, from drug-in-adhesive systems to matrix configurations, as well as the nuanced deployment of active ingredients such as buprenorphine, clonidine, fentanyl, lidocaine, and nicotine. The disaggregation into various delivery systems and specialized applications further emphasizes the market's depth. Regional assessments articulate how varying economic and regulatory environments in the Americas, Europe, the Middle East, Africa, and Asia-Pacific are determining localized market behavior.

As many companies continue to innovate, they foster competitive environments where clinical efficacy, patient-centric design, and sustainable practices are key drivers of success. This analysis not only offers clarity on where the market is headed but also provides strategic insights necessary for navigating its complexities. The conclusions drawn here serve as a valuable framework for industry stakeholders seeking long-term stability and growth in an evolving therapeutic landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand in the home healthcare sector for practical and efficient medication management solutions
      • 5.1.1.2. Rising prevalence of chronic diseases necessitating alternative pain management solutions
      • 5.1.1.3. New technological advancements improving the efficacy and convenience of transdermal patches
    • 5.1.2. Restraints
      • 5.1.2.1. Biocompatibility issues impacting the effectiveness and safety of transdermal patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Integrating IoT technology into smart transdermal patches for real-time health monitoring
      • 5.1.3.2. Rapid growth in personalized medicine creates demand for customizable transdermal patch solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Tackling intellectual property and patent expiration threats in the transdermal patch industry
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type : Significant penetration of multi-layer drug-in-adhesive patches due to its ability to house complex medication combinations
    • 5.2.2. End User : Growing need of patches with a broad spectrum in hospitals & clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transdermal Patches Market, by Product Type

  • 6.1. Introduction
  • 6.2. Drug-In-Adhesive Patches
    • 6.2.1. Multi-Layer Drug-In-Adhesive Patches
    • 6.2.2. Single-Layer Drug-In-Adhesive Patches
  • 6.3. Matrix Patches
    • 6.3.1. Multi-Layer Matrix
    • 6.3.2. Single-Layer Matrix
  • 6.4. Micro-Reservoir Patches

7. Transdermal Patches Market, by Active Ingredient

  • 7.1. Introduction
  • 7.2. Buprenorphine
  • 7.3. Clonidine
  • 7.4. Fentanyl
  • 7.5. Lidocaine
  • 7.6. Nicotine

8. Transdermal Patches Market, by Delivery System

  • 8.1. Introduction
  • 8.2. Controlled Release
  • 8.3. Direct Release

9. Transdermal Patches Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Disorders
    • 9.2.1. Clonidine Patches
    • 9.2.2. Isosorbide Dinitrate Patches
  • 9.3. Hormone Replacement Therapy
    • 9.3.1. Combination Hormone Patches
    • 9.3.2. Estrogen Patches
    • 9.3.3. Progestin Patches
  • 9.4. Neurological Conditions
  • 9.5. Pain Management
    • 9.5.1. Diclofenac-Based
    • 9.5.2. Fentanyl-Based
    • 9.5.3. Lidocaine-Based
  • 9.6. Smoking Cessation
  • 9.7. Wound Management

10. Transdermal Patches Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Homecare Settings
  • 10.4. Hospitals & Clinics
  • 10.5. Research & Academic Institutes

11. Transdermal Patches Market, by Layer Type

  • 11.1. Introduction
  • 11.2. Multi-Layer
  • 11.3. Single Layer

12. Americas Transdermal Patches Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Transdermal Patches Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. China Grants approval for Sino Biopharm's first domestic rivastigmine transdermal patch for alzheimer's treatment
    • 15.3.2. Agile Therapeutics finalizes acquisition by Insud Pharma enhancing product portfolio
    • 15.3.3. Jolt Health Inc. to enhance treatment options with acquisition of HCQ transdermal patch technology
    • 15.3.4. Medherant and Bayer collaborate to innovate transdermal patch delivery for oral medicines
    • 15.3.5. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
    • 15.3.6. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
    • 15.3.7. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
    • 15.3.8. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
    • 15.3.9. Almirall Acquires Rights To Distribute Alzheimer's Treatment In Spain For An Initial EUR 45 Million
    • 15.3.10. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
    • 15.3.11. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
    • 15.3.12. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
    • 15.3.13. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.14. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.15. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
    • 15.3.16. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma's Growth Path
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AdhexPharma SAS
  • 3. Amneal Pharmaceuticals, Inc.
  • 4. Bayer AG
  • 5. BioNxt Solutions Inc.
  • 6. Bliss GVS Pharma Ltd.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Corium, Inc.
  • 9. Corsair Pharma, Inc.
  • 10. DifGen Pharmaceuticals LLC
  • 11. Endo International plc
  • 12. Gedeon Richter Plc
  • 13. GlaxoSmithKline Plc
  • 14. Icure Pharmaceutical Inc.
  • 15. Johnson & Johnson Services, Inc.
  • 16. LAVIPHARM GROUP HOLDING S.A.
  • 17. Lohmann Therapie-Systeme AG
  • 18. Luye Pharma Group Ltd
  • 19. Medherant Limited
  • 20. Nitto Denko Corporation
  • 21. Novartis AG
  • 22. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
  • 23. Nutriband Inc
  • 24. Perrigo Company plc
  • 25. ProSolus, Inc.
  • 26. Purdue Pharma L.P.
  • 27. Sparsha Pharma International Pvt Ltd
  • 28. Teikoku Seiyaku Co., Ltd.
  • 29. Teva Pharmaceutical Industries Ltd.
  • 30. Viatris Inc.
  • 31. Zydus Group

LIST OF FIGURES

  • FIGURE 1. TRANSDERMAL PATCHES MARKET MULTI-CURRENCY
  • FIGURE 2. TRANSDERMAL PATCHES MARKET MULTI-LANGUAGE
  • FIGURE 3. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
  • FIGURE 4. TRANSDERMAL PATCHES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 314. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 316. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 324. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
  • TABLE 325. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 327. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHE